Target intelligence / Profile preview

Glucocorticoid modulatory element-binding protein 2 (GMEB2)

Target
GMEB2
Molecular classification
Transcription factor, Other (coactivator, DNA-binding protein)
01

Overview

Glucocorticoid modulatory element-binding protein 2 (GMEB2) is a member of the KDWK gene family and functions as a transcription factor that modulates glucocorticoid receptor-mediated gene expression by binding to specific DNA sequences—glucocorticoid modulatory elements (GMEs)[1][4][6]. It forms complexes (homo- and heterooligomers) with related proteins such as GMEB1, thereby influencing the sensitivity and transcriptional activity of glucocorticoid receptor complexes, independent of receptor abundance[1][4]. GMEB2 also acts as an essential auxiliary protein in the replication of parvoviruses, interacting with viral and cellular promoters[4][6]. Structurally, it is not a membrane protein but acts intracellularly, primarily in the nucleus as a DNA-binding co-activator. Recent research implicates GMEB2 in the positive regulation of genes involved in cancer cell growth, particularly via NF-κB signaling pathways, and it is under investigation for roles in stress response and possibly other diseases[1].

Other names
KIAA1269GMEB-2PIF p79P79PIFPIF79DNA-binding protein p79PIFParvovirus initiation factor p79
02

Mechanism of action

Drugs targeting this molecule would predominantly act as inhibitors or modulators of transcriptional coactivation and/or DNA binding; however, no clinically approved drugs specifically target GMEB2.

03

Biological functions

Modulation of glucocorticoid receptor (GR) transcriptional activityPositive regulation of gene expression in response to glucocorticoidsBinding to glucocorticoid modulatory elements on DNAEssential auxiliary factor for parvovirus DNA replicationFormation of protein oligomers (homo- and heterooligomerization)
04

Disease associations

Cancer (notably implicated in colorectal cancer and support of cell growth via NF-κB signaling)Infection (essential for parvovirus replication)Other (potential roles in stress response, based on transcriptional regulation)
05

Safety considerations

None specifically documented; therapeutic manipulation could potentially disrupt stress response, glucocorticoid signaling, or viral susceptibility

Beyond the preview

Go deeper on Glucocorticoid modulatory element-binding protein 2 (GMEB2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Glucocorticoid modulatory element-binding protein 2 (GMEB2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call